OTCPK:VMTF

Stock Analysis Report

Executive Summary

VMT Scientific, Inc. engages in the design, development, testing, and patenting of medical technologies for use in tissue histogenesis.

Snowflake

Fundamentals

Adequate balance sheet with weak fundamentals.

Risks

  • VMT Scientific's last earnings update was 7067 days ago.
  • VMT Scientific is not covered by any analysts.
  • VMT Scientific is a small market cap stock, these often have low liquidity.

Share Price & News

How has VMT Scientific's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

0%

OTCPK:VMTF

-1.2%

US Medical Equipment

1.2%

US Market


1 Year Return

n/a

OTCPK:VMTF

8.7%

US Medical Equipment

1.7%

US Market

No trading data on VMTF.

No trading data on VMTF.


Share holder returns

VMTFIndustryMarket
7 Day0%-1.2%1.2%
30 Dayn/a1.4%4.9%
90 Dayn/a4.8%3.7%
1 Yearn/a9.6%8.7%3.9%1.7%
3 Year-93.0%-93.0%70.8%65.5%47.2%37.7%
5 Yearn/a130.4%104.1%60.0%42.4%

Price Volatility Vs. Market

How volatile is VMT Scientific's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is VMT Scientific undervalued based on future cash flows and its price relative to the stock market?


In this section, we usually try to help investors determine whether VMT Scientific is trading at an attractive price based on the cash flow it is expected to produce in the future. But as VMT Scientific has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Next Steps

  • Examine VMT Scientific's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
  • When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don’t know where to start, we recommend reading through VMT Scientific regulatory filings here.
  • Explore potentially undervalued companies in the Healthcare industry.

Future Growth

How is VMT Scientific expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

22.6%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as VMT Scientific has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has VMT Scientific performed over the past 5 years?

0.2%

Historical Healthcare annual earnings growth


In this section we usually display a company’s past earnings and revenues to help investors visualise the trend through time. We also gauge the company’s performance by benchmarking its returns and growth to its industry peers and the wider market. However, VMT Scientific has not provided sufficient past data to assess its track record.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have historical data.


Next Steps

Financial Health

How is VMT Scientific's financial position?


In this section we usually analyse VMT Scientific's finance health to determine how well-positioned it is against times of financial distress, in particular, its ability to manage its cash and debt levels. VMT Scientific has not provided adequate balance sheet data, its financial health cannot be properly assessed as it.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have financial information.


Next Steps

  • Take a look at our analysis of VMTF’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • Investors tend to look at the financial health of a company this size in order to assess the sustainability of its current operations. While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website.
  • Financial health is measured at one point in time, so the latest financial report is the best representation of the company’s current financial status. Check when VMT Scientific's financial data was last updated here.
  • Explore more healthy companies in the Healthcare industry.

Dividend

What is VMT Scientific's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate VMT Scientific's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate VMT Scientific's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as VMT Scientific has not reported any payouts.

Unable to verify if VMT Scientific's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as VMT Scientific has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of VMT Scientific's salary, the management and board of directors tenure and is there insider trading?


CEO

William Ko (51yo)

20.8yrs

Tenure

0

William W.N. Ko has been President, Chief Executive Officer and Director of Belair Enterprises Inc. since November 1998. Mr. Ko has also been Secretary, Chief Financial Officer and Controller of Belair Ent ...


Insider Trading

No 3 month open market individual insider trading information.


Management Team

  • William Ko (51yo)

    Chief Executive Officer

    • Tenure: 20.8yrs

Board Members

  • Jack Augsback (75yo)

    Director

    • Tenure: 20.2yrs
  • William Ko (51yo)

    Chief Executive Officer

    • Tenure: 20.8yrs

Company Information

VMT Scientific, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: VMT Scientific, Inc.
  • Ticker: VMTF
  • Exchange: OTCPK
  • Founded:
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: US$1.000
  • Shares outstanding: 241.44k
  • Website: https://null

Location

  • VMT Scientific, Inc.
  • 701 North Green Valley Parkway
  • Suite 200
  • Henderson
  • Nevada
  • 89074
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
VMTFOTCPK (Pink Sheets LLC)YesCommon StockUSUSDOct 1998

Biography

VMT Scientific, Inc. engages in the design, development, testing, and patenting of medical technologies for use in tissue histogenesis. It develops VasCir system, a noninvasive method of assisting tissue r ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/15 23:55
End of Day Share Price2019/08/20 00:00
Earnings2000/01/31
Annual Earnings1999/04/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.